Detailed information for compound 1467118

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 343.205 | Formula: C15H16Cl2N2O3
  • H donors: 1 H acceptors: 1 LogP: 2.93 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: CO[C@@H]1CC=C2[C@](O1)(C)CC(=O)N(N2)c1cc(Cl)cc(c1)Cl
  • InChi: 1S/C15H16Cl2N2O3/c1-15-8-13(20)19(11-6-9(16)5-10(17)7-11)18-12(15)3-4-14(21-2)22-15/h3,5-7,14,18H,4,8H2,1-2H3/t14-,15-/m0/s1
  • InChiKey: VCQQBOWKLYIDIT-GJZGRUSLSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni serine/threonine protein kinase 0.0091 0.594 0.5827
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Onchocerca volvulus Serine\/threonine kinase homolog 0.0091 0.594 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0045 0.2502 0.389
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0016 0.0313 0.0075
Schistosoma mansoni transcription factor LCR-F1 0.0035 0.1725 0.1495
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0046 0.254 0.3025
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0016 0.0313 0.0075
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0044 0.2429 0.2218
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0104 0.6906 0.8844
Entamoeba histolytica serine/threonine protein kinase, putative 0.0091 0.594 1
Plasmodium vivax dihydrolipoyl dehydrogenase, mitochondrial, putative 0.0016 0.0313 0.0186
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0035 0.1725 0.2565
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0016 0.0313 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0044 0.2429 0.3807
Loa Loa (eye worm) thioredoxin reductase 0.0046 0.254 0.304
Loa Loa (eye worm) MH2 domain-containing protein 0.0115 0.7736 1
Leishmania major trypanothione reductase 0.0046 0.254 0.4003
Plasmodium falciparum glutathione reductase 0.0046 0.254 1
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0016 0.0313 0.5
Trypanosoma brucei dihydrolipoamide dehydrogenase, point mutation 0.0016 0.0313 0.0075
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast 0.0016 0.0313 0.0186
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0091 0.594 1
Treponema pallidum NADH oxidase 0.0016 0.0313 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0045 0.2502 0.389
Mycobacterium tuberculosis Probable dehydrogenase 0.0104 0.6906 0.8844
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.0046 0.254 0.4003
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Mycobacterium tuberculosis Probable reductase 0.0104 0.6906 0.8844
Trypanosoma cruzi trypanothione reductase, putative 0.0046 0.254 0.4003
Trypanosoma cruzi trypanothione reductase, putative 0.0016 0.0313 0.0075
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0016 0.0313 0.5
Brugia malayi Thioredoxin reductase 0.0046 0.254 0.3284
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0016 0.0313 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0044 0.2429 0.2218
Loa Loa (eye worm) glutathione reductase 0.0046 0.254 0.304
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0016 0.0313 0.5
Leishmania major acetoin dehydrogenase e3 component-like protein 0.0016 0.0313 0.0075
Toxoplasma gondii thioredoxin reductase 0.0046 0.254 1
Trypanosoma brucei dihydrolipoyl dehydrogenase 0.0016 0.0313 0.0075
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0016 0.0313 0.0075
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0091 0.594 0.7594
Leishmania major 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein 0.0016 0.0313 0.0075
Plasmodium falciparum dihydrolipoyl dehydrogenase, mitochondrial 0.0016 0.0313 0.0186
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0016 0.0313 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0116 0.7773 1
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Mycobacterium tuberculosis Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot 0.0016 0.0313 0.0056
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0044 0.2429 0.314
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0104 0.6906 0.8844
Brugia malayi serine/threonine-protein kinase plk-2 0.0091 0.594 0.7678
Brugia malayi isocitrate dehydrogenase 0.0015 0.0271 0.0351
Trypanosoma cruzi polo-like protein kinase, putative 0.0091 0.594 1
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Brugia malayi hypothetical protein 0.0035 0.1725 0.223
Trypanosoma brucei polo-like protein kinase 0.0091 0.594 1
Plasmodium falciparum glutathione reductase 0.0016 0.0313 0.0186
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Schistosoma mansoni hypothetical protein 0.0035 0.1725 0.1495
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0116 0.7773 1
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0016 0.0313 0.0043
Schistosoma mansoni kinase 0.0046 0.2592 0.2386
Loa Loa (eye worm) transcription factor SMAD2 0.0115 0.7736 1
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0016 0.0313 0.0075
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0091 0.594 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0044 0.2429 0.2891
Brugia malayi glutathione reductase 0.0046 0.254 0.3284
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0104 0.6906 0.8844
Giardia lamblia Kinase, PLK 0.0091 0.594 1
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0091 0.594 1
Trypanosoma brucei trypanothione reductase 0.0046 0.254 0.4003
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Brugia malayi Isocitrate dehydrogenase 0.0015 0.0271 0.0351
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0044 0.2429 0.2218
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0016 0.0313 0.0075
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0044 0.2429 0.3807
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Plasmodium vivax glutathione reductase, putative 0.0046 0.254 1
Plasmodium vivax thioredoxin reductase, putative 0.0046 0.254 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0044 0.2429 0.3807
Trichomonas vaginalis CAMK family protein kinase 0.0091 0.594 1
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0016 0.0313 0.0405
Echinococcus granulosus thioredoxin glutathione reductase 0.0046 0.254 0.4003
Plasmodium falciparum thioredoxin reductase 0.0046 0.254 1
Toxoplasma gondii pyruvate dehydrogenase complex subunit PDH-E3II 0.0016 0.0313 0.0186
Plasmodium falciparum thioredoxin reductase 0.0016 0.0313 0.0186
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0104 0.6906 0.8844
Trypanosoma cruzi polo-like protein kinase, putative 0.0091 0.594 1
Plasmodium vivax dihydrolipoyl dehydrogenase, apicoplast, putative 0.0016 0.0313 0.0186
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0035 0.1725 0.2565
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0044 0.2429 0.3807
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0116 0.7773 1
Toxoplasma gondii NADPH-glutathione reductase 0.0016 0.0313 0.0186
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0016 0.0313 0.0075
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0016 0.0313 0.0075
Brugia malayi MH2 domain containing protein 0.0115 0.7736 1
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0116 0.7773 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 17.48 uM Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay ChEMBL. 20884086
IC50 (functional) = 18.8 uM Growth inhibition of human SK-BR-3 cells after 48 hrs by sulforhodamine B assay ChEMBL. 20884086
IC50 (functional) = 19.4 uM Growth inhibition of human HCT116 cells after 48 hrs by sulforhodamine B assay ChEMBL. 20884086
IC50 (functional) = 20.2 uM Growth inhibition of human SK-N-SH cells after 48 hrs by sulforhodamine B assay ChEMBL. 20884086
IC50 (functional) = 21.29 uM Growth inhibition of human DU145 cells after 48 hrs by sulforhodamine B assay ChEMBL. 20884086

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 20884086

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.